Enanta Pharmaceuticals Stock News

Palisade Asset Management LLC decreased its position in shares of AbbVie Inc (NYSE:ABBV) by 19.9% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commissio

Selway Asset Management increased its holdings in shares of AbbVie Inc (NYSE:ABBV) by 0.5% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Co

Woodard & Co. Asset Management Group Inc. ADV raised its position in shares of AbbVie Inc (NYSE:ABBV) by 3.6% in the second quarter, according to its most recent 13F filing with the Securities & Excha

Grandfield & Dodd LLC raised its holdings in AbbVie Inc (NYSE:ABBV) by 5.2% during the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 5,562 shares

Click HERE to find out ⭐ China: WeiyangX Fintech Review. | Crowdfund Insider: Global Fintech News, including Crowdfunding, Blockchain and more.

California voters who are weary of ballot measures asking them to approve more debt and higher taxes for education will find no respite on the November ballot.

The company said it was formally terminating the Phase III study of the drug elafibranor in NASH and refocus its development of the drug on another disease, primary biliary cholangitis, as well as a d

The FDA has lifted a hold on clinical trials for an experimental CymaBay Therapeutics drug in three liver diseases, clearing the way for tests to resume

France’s Genfit has said its elafibranor drug as a treatment for non-alcoholic steatohepatitis (NASH) was unable to improve

A review of all baby bonds. All the baby bonds sorted in categories.

Security Council members are set to hold an informal interactive dialogue (IID) with representatives of the Peacebuilding Commission (PBC) on the impact of the novel coronavirus pandemic on conflict-a

AbbVie Inc (NYSE:ABBV)’s stock price hit a new 52-week high during mid-day trading on Friday . The company traded as high as $100.86 and last traded at $100.42, with a volume of 106159 shares changi

Insider trades are very informative to include in your investment strategy as insiders know their business better than anyone else.

Equities analysts expect that AbbVie Inc (NYSE:ABBV) will post $10.06 billion in sales for the current quarter, according to Zacks. Two analysts have made estimates for AbbVie’s earnings, with the l

It is hard to get excited after looking at Enanta Pharmaceuticals' (NASDAQ:ENTA) recent performance, when its stock...